Company intelligence / Profile preview

MR Solutions

Guildford, Surrey, United Kingdom

Ownership: Private
Development stage: Other

Overview

MR Solutions is the world leader in cryogen-free preclinical MRI, PET, SPECT, and CT imaging systems used for advanced molecular imaging in a wide range of indications such as oncology, cardiology, neurology, inflammation, and nephritis. Over 2,500 systems are installed worldwide; no drug clinical development is tracked as this is not a therapeutic or drug company[1][2][4].

Therapeutic areas: NephrologyCardiovascularImmunologyNeurologyOtherOncology
Modalities: Device
Industry: Medical Imaging

Partnerships

Summit Pharmaceuticals International (Japan distribution)[4]Academic research institutes (multiple installations and workshops)[4]

Beyond the preview

Go deeper on MR Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on MR Solutions.

Explore the full profile